These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27302328)

  • 1. Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza Vaccination.
    Stockwell MS; Broder KR; Lewis P; Jakob K; Iqbal S; Fernandez N; Sharma D; Barrett A; LaRussa P
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e7-e14. PubMed ID: 27302328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.
    Stockwell MS; Marchant CD; Wodi AP; Barnett ED; Broder KR; Jakob K; Lewis P; Kattan M; Rezendes AM; Barrett A; Sharma D; Fernandez N; LaRussa P
    Vaccine; 2017 Dec; 35(50):6941-6948. PubMed ID: 29089191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.
    Stockwell MS; Broder K; LaRussa P; Lewis P; Fernandez N; Sharma D; Barrett A; Sosa J; Vellozzi C
    JAMA Pediatr; 2014 Mar; 168(3):211-9. PubMed ID: 24395025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
    Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Baxter R; Eaton A; Hansen J; Aukes L; Caspard H; Ambrose CS
    Vaccine; 2017 Mar; 35(9):1254-1258. PubMed ID: 28162825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.
    Grohskopf LA; Sokolow LZ; Broder KR; Walter EB; Fry AM; Jernigan DB
    MMWR Recomm Rep; 2018 Aug; 67(3):1-20. PubMed ID: 30141464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial.
    Loeb M; Russell ML; Manning V; Fonseca K; Earn DJ; Horsman G; Chokani K; Vooght M; Babiuk L; Schwartz L; Neupane B; Singh P; Walter SD; Pullenayegum E
    Ann Intern Med; 2016 Nov; 165(9):617-624. PubMed ID: 27538259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Live Attenuated Influenza Vaccine in Children With Asthma.
    Sokolow AG; Stallings AP; Kercsmar C; Harrington T; Jimenez-Truque N; Zhu Y; Sokolow K; Moody MA; Schlaudecker EP; Walter EB; Staat MA; Broder KR; Creech CB
    Pediatrics; 2022 Apr; 149(4):. PubMed ID: 35342923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
    Haber P; Moro PL; Lewis P; Woo EJ; Jankosky C; Cano M
    Vaccine; 2016 May; 34(22):2507-12. PubMed ID: 27015735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink.
    Caspard H; Steffey A; Mallory RM; Ambrose CS
    BMJ Open; 2018 Dec; 8(12):e023118. PubMed ID: 30530581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
    Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M
    Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study.
    Airey J; Albano FR; Sawlwin DC; Jones AG; Formica N; Matassa V; Leong J
    Vaccine; 2017 May; 35(20):2745-2752. PubMed ID: 28390934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
    Treanor JT; Albano FR; Sawlwin DC; Graves Jones A; Airey J; Formica N; Matassa V; Leong J
    Vaccine; 2017 Apr; 35(15):1856-1864. PubMed ID: 28302411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children.
    Sawlwin DC; Graves Jones A; Albano FR
    Vaccine; 2019 Apr; 37(18):2447-2454. PubMed ID: 30935743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
    Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
    JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live versus attenuated influenza vaccine uptake and post-vaccination influenza-like illness outcomes in HIV-infected US Air Force members.
    Menegay JL; Xu X; Sunil TS; Okulicz JF
    J Clin Virol; 2017 Oct; 95():72-75. PubMed ID: 28889083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.
    Kahn KE; Santibanez TA; Zhai Y; Singleton JA
    Vaccine; 2015 Sep; 33(39):5196-203. PubMed ID: 26238724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    Krishnan A; Dar L; Saha S; Narayan VV; Kumar R; Kumar R; Amarchand R; Dhakad S; Chokker R; Choudekar A; Gopal G; Choudhary A; Potdar V; Chadha M; Lafond KE; Lindstrom S; Widdowson MA; Jain S
    PLoS Med; 2021 Apr; 18(4):e1003609. PubMed ID: 33914729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
    Salamanca de la Cueva I; Cinconze E; Eckermann T; Nwoji U; Godderis L; Lu E; Martínez-Gómez X; Wang H; Yanni E
    Drug Saf; 2021 Dec; 44(12):1375-1390. PubMed ID: 34694589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.